2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Jan Steffel*, Ronan Collins, Matthias Antz, Pieter Cornu, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, Peter Sinnaeve, Thomas Vanassche, Tatjana Potpara, A John Camm, Hein Heidbüchel, External reviewers:, Gregory Y H Lip (Member of study group), Thomas Deneke (Member of study group), Nikolaos Dagres (Member of study group), Giuseppe Boriani (Member of study group)Tze-Fan Chao (Member of study group), Eue-Keun Choi (Member of study group), Mellanie True Hills (Member of study group), Itamar de Souza Santos (Member of study group), Deirdre A Lane (Member of study group), Dan Atar (Member of study group), Boyoung Joung (Member of study group), Oana Maria Cole (Member of study group), Mark Field (Member of study group)

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

189 Citations (Scopus)
Original languageEnglish
JournalEuropace
Volume23
Issue number10
Pages (from-to)1612-1676
Number of pages65
ISSN1099-5129
DOIs
Publication statusPublished - 9 Oct 2021

Keywords

  • DOACs
  • NOACs
  • apixaban
  • dabigatran
  • edoxaban
  • rivaroxaban

Cite this